Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 3
2010 1
2011 4
2012 1
2013 5
2014 3
2015 2
2016 3
2017 2
2018 2
2019 3
2020 10
2021 5
2022 5
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?
Porcaro AB, Bianchi A, Panunzio A, Gallina S, Serafin E, Tafuri A, Trabacchin N, Orlando R, Ornaghi PI, Mazzucato G, Vidiri S, D'Aietti D, Montanaro F, Brusa D, Patuzzo GM, Artoni F, Baielli A, Migliorini F, De Marco V, Veccia A, Brunelli M, Siracusano S, Cerruto MA, Antonelli A. Porcaro AB, et al. Among authors: brusa d. Int Urol Nephrol. 2024 Mar 30. doi: 10.1007/s11255-024-04019-3. Online ahead of print. Int Urol Nephrol. 2024. PMID: 38553619
Postoperative outcomes of transperitoneal versus retroperitoneal robotic partial nephrectomy: a propensity-score matched comparison focused on patient mobilization, return to bowel function, and pain.
Bertolo R, Ditonno F, Veccia A, De Marco V, Migliorini F, Porcaro AB, Rizzetto R, Cerruto MA, Autorino R, Antonelli A; PubMed-indexed collaborators. Bertolo R, et al. J Robot Surg. 2024 Feb 28;18(1):96. doi: 10.1007/s11701-024-01860-7. J Robot Surg. 2024. PMID: 38413473 Free PMC article.
Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy.
Porcaro AB, Panunzio A, Bianchi A, Cerrato C, Gallina S, Serafin E, Mazzucato G, Vidiri S, D'Aietti D, Orlando R, Brusa D, Brunelli M, Siracusano S, Pagliarulo V, Cerruto MA, Tafuri A, Antonelli A. Porcaro AB, et al. Among authors: brusa d. Ther Adv Urol. 2023 Feb 22;15:17562872231154150. doi: 10.1177/17562872231154150. eCollection 2023 Jan-Dec. Ther Adv Urol. 2023. PMID: 36846295 Free PMC article.
Clinical implications of endogenous testosterone density on prostate cancer progression in patients with very favorable low and intermediate risk treated with radical prostatectomy.
Porcaro AB, Tafuri A, Panunzio A, Cerrato C, Bianchi A, Gallina S, Vidiri S, D'Aietti D, Serafin E, Mazzucato G, Princiotta A, Brusa D, Brunelli M, Pagliarulo V, Cerruto MA, Antonelli A. Porcaro AB, et al. Among authors: brusa d. Asian J Androl. 2023 Jan 6;25(5):556-63. doi: 10.4103/aja202298. Online ahead of print. Asian J Androl. 2023. PMID: 36629157 Free PMC article.
Medium supplementation can influence the human ovarian cells in vitro.
Dadashzadeh A, Moghassemi S, Grubliauskaité M, Vlieghe H, Brusa D, Amorim CA. Dadashzadeh A, et al. Among authors: brusa d. J Ovarian Res. 2022 Dec 26;15(1):137. doi: 10.1186/s13048-022-01081-2. J Ovarian Res. 2022. PMID: 36572931 Free PMC article.
Preoperative endogenous testosterone density predicts disease progression from localized impalpable prostate cancer presenting with PSA levels elevated up to 10 ng/mL.
Porcaro AB, Bianchi A, Mazzucato G, Gallina S, Serafin E, Tafuri A, Cerrato C, Panunzio A, Vidiri S, D'Aietti D, Orlando R, Brusa D, Brunelli M, Siracusano S, Cerruto MA, Antonelli A. Porcaro AB, et al. Among authors: brusa d. Int Urol Nephrol. 2023 Jan;55(1):85-92. doi: 10.1007/s11255-022-03366-3. Epub 2022 Oct 5. Int Urol Nephrol. 2023. PMID: 36197572 Free PMC article.
54 results